22 22. Kawamura O, Easterling C, Aslam M, Rittmann T, Hofmann C, Shaker R. Laryngo‐upper esophageal sphincter contractile reflex in humans deteriorates with age. Gastroenterology. 2004; 127(1):57–64.
23 23. Kawami N, Iwakiri K, Sano H, Tanaka Y, Sakamoto C. Effects of aging and acid reflux on esophageal motility. Digestion. 2015; 91(3):181–186.
24 24. Gregersen H, Pedersen J, Drewes AM. Deterioration of muscle function in the human esophagus with age. Dig Dis Sci. 2008; 53(12):3065–3070.
25 25. Firth M, Prather CM. Gastrointestinal motility problems in the elderly patient. Gastroenterology. 2002; 122(6):1688–1700.
26 26. Lee J, Anggiansah A, Anggiansah R, Young A, Wong T, Fox M. Effects of age on the gastroesophageal junction, esophageal motility, and reflux disease. Clin Gastroenterol Hepatol. 2007; 5(12):1392–1398.
27 27. Smout AJ, Breedijk M, van der Zouw C, Akkermans LM. Physiological gastroesophageal reflux and esophageal motor activity studied with a new system for 24‐hour recording and automated analysis. Dig Dis Sci.1989; 34(3):372–378.
28 28. Tack J, Vantrappen G. The aging oesophagus. Gut.1997; 41:422–424.
29 29. Shaker R, Staff D. Esophageal disorders in the elderly. Gastroenterol Clin North Am. 2001; 30(2):335–361, vii–viii.
30 30. Lock G. Physiology and pathology of the oesophagus in the elderly patient. Best Pract Res Clin Gastroenterol. 2001; 15(6):919–941.
31 31. Veerappan GR, Perry JL, Duncan TJ, et al. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin Gastroenterol Hepatol. 2009; 7(4):420–426,426 e421‐422.
32 32. Orr WC, Chen CL. Aging and neural control of the GI tract: IV. Clinical and physiological aspects of gastrointestinal motility and aging. Am J Physiol Gastrointest Liver Physiol. 2002; 283(6):G1226–1231.
33 33. Kahrilas PJ, Pandolfino JE. Treatments for achalasia in 2017: how to choose among them. Curr Opin Gastroenterol. 2017; 33(4):270–276.
34 34. Rohof WO, Salvador R, Annese V, et al. Outcomes of treatment for achalasia depend on manometric subtype. Gastroenterology. 2013; 144(4):718–725; quiz e713‐714.
35 35. Craft RO, Aguilar BE, Flahive C, et al. Outcomes of minimally invasive myotomy for the treatment of achalasia in the elderly. JSLS. 2010; 14(3):342–347.
36 36. Sandler RS, Nyren O, Ekbom A, Eisen GM, Yuen J, Josefsson S. The risk of esophageal cancer in patients with achalasia. A population‐based study. Jama.1995; 274(17):1359–1362.
37 37. Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015; 27(2):160–174.
38 38. Zarowitz BJ. Pharmacologic consideration of commonly used gastrointestinal drugs in the elderly. Gastroenterol Clin North Am. 2009; 38(3):547–562.
39 39. Matsumoto Y, Senda E, Yamada H. Dabigatran‐induced esophagitis associated with vomiting. Am J Gastroenterol. 2019; 114(4):548.
40 40. Eslick GD, Fass R. Noncardiac chest pain: evaluation and treatment. Gastroenterol Clin North Am. 2003; 32(2):531–552.
41 41. George N, Abdallah J, Maradey‐Romero C, Gerson L, Fass R. Review article: the current treatment of non‐cardiac chest pain. Aliment Pharmacol Ther. 2016; 43(2):213–239.
42 42. Eslick GD, Talley NJ. Natural history and predictors of outcome for non‐cardiac chest pain: a prospective4‐year cohort study. Neurogastroenterol Motil. 2008; 20(9):989–997.
43 43. Achem SR, DeVault KR. Gastroesophageal reflux disease and the elderly. Gastroenterol Clin North Am. 2014; 43(1):147–160.
44 44. Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton‐pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf. 2017; 8(9):273–297.
45 45. Malfertheiner P, Kandulski A, Venerito M. Proton‐pump inhibitors: understanding the complications and risks. Nat Rev Gastroenterol Hepatol. 2017; 14(12):697–710.
46 46. Pham H, Phillips L, Trahair L, Hatzinikolas S, Horowitz M, Jones KL. Longitudinal changes in the blood pressure responses to, and gastric emptying of, an oral glucose load in healthy older subjects. J Gerontol A Biol Sci Med Sci. 2019.
47 47. Gidal BE. Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs. Epilepsy Res. 2006; 68 Suppl1:S65‐69.
48 48. Soenen S, Rayner CK, Horowitz M, Jones KL. Gastric emptying in the elderly. Clin Geriatr Med. 2015; 31(3):339–353.
49 49. Camilleri M, Chedid V, Ford AC, et al. Gastroparesis. Nat Rev Dis Primers. 2018; 4(1):41.
50 50. Fich A, Camilleri M, Phillips SF. Effect of age on human gastric and small bowel motility. J Clin Gastroenterol.1989; 11:416–420.
51 51. Serra‐Prat M, Mans E, Palomera E, Clave P. Gastrointestinal peptides, gastrointestinal motility, and anorexia of aging in frail elderly persons. Neurogastroenterol Motil. 2013; 25(4):291–e245.
52 52. Visvanathan R, Chapman IM. Undernutrition and anorexia in the older person. Gastroenterol Clin North Am. 2009; 38(3):393–409.
53 53. Salles N. Basic mechanisms of the aging gastrointestinal tract. Dig Dis. 2007; 25(2):112–117.
54 54. Husebye E, Engedal K. The patterns of motility are maintained in the human small intestine throughout the process of aging. Scand J Gastroenterol.1992; 27:397–404.
55 55. Mitsui T, Kagami H, Kinomoto H, Ito A, Kondo T, Shimaoka K. Small bowel bacterial overgrowth and rice malabsorption in healthy and physically disabled older adults. J Hum Nutr Diet. 2003; 16(2):119–122.
56 56. Schiller LR. Diarrhea and malabsorption in the elderly. Gastroenterol Clin North Am. 2009; 38(3):481–502.
57 57. Thomson AB. Small intestinal disorders in the elderly. Best Pract Res Clin Gastroenterol. 2009; 23(6):861–874.
58 58. Pimentel M. Review of rifaximin as treatment for SIBO and IBS. Expert Opin Investig Drugs. 2009; 18(3):349–358.
59 59. Trahair LG, Horowitz M, Jones KL. Postprandial hypotension: a systematic review. J Am Med Dir Assoc. 2014; 15(6):394–409.
60 60. Jones KL, Rigda RS, Buttfield MDM, et al. Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetes. Diabetes Obes Metab. 2019; 21(5):1158–1167.
61 61. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurol. 2003;2( 2):107–116.
62 62. Natale G, Pasquali L, Ruggieri S, Paparelli A, Fornai F. Parkinson’s disease and the gut: a well known clinical association in need of an effective cure and explanation. Neurogastroenterol Motil. 2008; 20(7):741–749.
63 63. Leow LP, Huckabee ML, Anderson T, Beckert L. The impact of dysphagia on quality of life in ageing and Parkinson’s disease as measured by the swallowing quality of life (SWAL‐QOL) questionnaire. Dysphagia. 2010; 25(3):216–220.
64 64. Leow LP, Beckert L, Anderson T, Huckabee ML. Changes in chemosensitivity and mechanosensitivity in aging and Parkinson’s disease. Dysphagia. 2012; 27(1):106–114.
65 65. Heetun ZS, Quigley EM. Gastroparesis and Parkinson’s disease: a systematic review. Parkinsonism Relat Disord. 2012; 18(5):433–440.
66 66. Du YT, Rayner CK, Jones KL, Talley NJ, Horowitz M. Gastrointestinal symptoms in diabetes: prevalence, assessment, pathogenesis, and management. Diabetes Care. 2018; 41(3):627–637.
67 67. Kuo P, Rayner CK, Horowitz M. Gastric emptying, diabetes, and aging. Clin Geriatr Med. 2007; 23(4):785–808, vi.
68 68. Marathe CS, Rayner CK, Jones KL, Horowitz M. Relationships between gastric emptying, postprandial glycemia, and incretin hormones. Diabetes Care. 2013; 36(5):1396–1405.
69 69. Watson LE, Xie C, Wang X, et al. Gastric emptying in patients with well‐controlled